相似文献
1
Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways.
J Am Chem Soc. 2013 Sep 25;135(38):14060-3. doi: 10.1021/ja4075375. Epub 2013 Sep 16.
2
Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
J Inorg Biochem. 2014 Dec;141:121-131. doi: 10.1016/j.jinorgbio.2014.08.014. Epub 2014 Sep 6.
3
Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
Dalton Trans. 2014 Dec 7;43(45):17017-28. doi: 10.1039/c4dt01392a.
4
Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands.
Chem Commun (Camb). 2013 Nov 4;49(85):9980-2. doi: 10.1039/c3cc42250j.
5
Ru(ii)-(PTA) and -mPTA complexes with N-donor ligands bipyridyl and phenanthroline and their antiproliferative activities on human multiple myeloma cell lines.
Dalton Trans. 2017 Aug 14;46(30):10073-10081. doi: 10.1039/c7dt02051a. Epub 2017 Jul 21.
6
Osmium(VI) nitride triggers mitochondria-induced oncosis and apoptosis.
Chem Commun (Camb). 2022 Feb 17;58(15):2468-2471. doi: 10.1039/d1cc05148b.
7
Microwave synthesis of mixed ligand diimine-thiosemicarbazone complexes of ruthenium(II): biophysical reactivity and cytotoxicity.
Dalton Trans. 2009 Dec 28(48):10757-64. doi: 10.1039/b915081a. Epub 2009 Sep 28.
8
A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells.
Dalton Trans. 2020 Dec 15;49(47):17173-17182. doi: 10.1039/d0dt02715d.
9
A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.
J Am Chem Soc. 2014 Oct 15;136(41):14413-6. doi: 10.1021/ja508808v. Epub 2014 Oct 6.
10
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Eur J Med Chem. 2019 Aug 15;176:492-512. doi: 10.1016/j.ejmech.2019.04.070. Epub 2019 May 13.
引用本文的文献
1
Cyclometalated Benzimidazole Osmium(II) Complexes with Antiproliferative Activity in Cancer Cells Disrupt Calcium Homeostasis.
Inorg Chem. 2023 Apr 24;62(16):6474-6487. doi: 10.1021/acs.inorgchem.3c00501. Epub 2023 Apr 11.
2
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.
Molecules. 2022 Dec 29;28(1):273. doi: 10.3390/molecules28010273.
3
A Pyrazolate Osmium(VI) Nitride Exhibits Anticancer Activity through Modulating Protein Homeostasis in HepG2 Cells.
Int J Mol Sci. 2022 Oct 24;23(21):12779. doi: 10.3390/ijms232112779.
4
Targeting of the intracellular redox balance by metal complexes towards anticancer therapy.
Front Chem. 2022 Aug 11;10:967337. doi: 10.3389/fchem.2022.967337. eCollection 2022.
5
Metal Complexes for Therapeutic Applications.
Trends Chem. 2021 Jul;3(7):523-534. doi: 10.1016/j.trechm.2021.03.006. Epub 2021 Apr 14.
6
An amine template strategy to construct successive C-C bonds: synthesis of benzo[]quinolines by a deaminative ring contraction cascade.
Org Biomol Chem. 2022 Feb 16;20(7):1379-1385. doi: 10.1039/d1ob02245h.
7
NMR studies of group 8 metallodrugs: Os-enriched organo-osmium half-sandwich anticancer complex.
Dalton Trans. 2021 Sep 28;50(37):12970-12981. doi: 10.1039/d1dt02213j.
8
Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer.
Molecules. 2021 Sep 4;26(17):5386. doi: 10.3390/molecules26175386.
9
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.
J Biol Inorg Chem. 2021 Aug;26(5):535-549. doi: 10.1007/s00775-021-01873-9. Epub 2021 Jun 26.
10
Anticancer gold(iii)-bisphosphine complex alters the mitochondrial electron transport chain to induce tumor inhibition.
Chem Sci. 2021 Apr 29;12(21):7467-7479. doi: 10.1039/d1sc01418h.
本文引用的文献
1
The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway.
J Med Chem. 2013 Feb 14;56(3):1291-300. doi: 10.1021/jm3017442. Epub 2013 Jan 31.
2
Predicting cancer drug mechanisms of action using molecular network signatures.
Mol Biosyst. 2013 Jul;9(7):1604-19. doi: 10.1039/c2mb25459j. Epub 2013 Jan 4.
3
Defining principles of combination drug mechanisms of action.
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):E170-9. doi: 10.1073/pnas.1210419110. Epub 2012 Dec 18.
4
Endoplasmic reticulum (ER) stress inhibitor salubrinal protects against ceramide-induced SH-SY5Y cell death.
Biochem Biophys Res Commun. 2012 Oct 26;427(3):461-5. doi: 10.1016/j.bbrc.2012.08.068. Epub 2012 Aug 23.
5
Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
Dalton Trans. 2011 Oct 28;40(40):10553-62. doi: 10.1039/c1dt10937e. Epub 2011 Aug 22.
6
Osmium(VI) complexes as a new class of potential anti-cancer agents.
Chem Commun (Camb). 2011 Feb 21;47(7):2140-2. doi: 10.1039/c0cc04515b. Epub 2011 Jan 4.
7
A mammalian functional-genetic approach to characterizing cancer therapeutics.
Nat Chem Biol. 2011 Feb;7(2):92-100. doi: 10.1038/nchembio.503. Epub 2010 Dec 26.
8
Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
Dalton Trans. 2010 Aug 21;39(31):7345-52. doi: 10.1039/c003085f. Epub 2010 Jul 2.
9
Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells.
J Med Chem. 2010 Jan 28;53(2):840-9. doi: 10.1021/jm901556u.
10
Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response.
J Cell Biol. 2009 Nov 16;187(4):525-36. doi: 10.1083/jcb.200907074. Epub 2009 Nov 9.
Zotero 插件